Cell avidity-tuning ensures safe CAR-T therapy for solid tumors
Learn more about the potential of cell avidity in designing potent and safe CAR-T treatments for solid tumors.
Drug discovery
- Latest Posts
In Depth 17 Apr 2024
Small but mighty: The role of small-molecule drugs in disease treatment
Find out more about small-molecule drugs, including how they work and what their advantages and disadvantages are.
Podcast 8 Mar 2024
AI immune system mapping to boost drug discovery
Immunai is using artificial intelligence to map the immune system. The company hopes this will lead to better and faster drug discovery.
Protein inhibitors: cracking the code of disease mechanisms
Explore how protein inhibitors revolutionize disease understanding, by unlocking the secrets of disease pathways.
More sustainable drug development and lab sustainability
From reducing carbon footprints to optimising costs, explore innovative solutions for sustainable drug discovery and development!
Podcast 16 Feb 2024
How does AI help drug discovery?
Listen to our podcast to discover how AI is revolutionizing drug discovery by tackling “undruggable” cancer targets like KRAS.
ADVERTISEMENT
ADVERTISEMENT
Expert Advice 2 Feb 2024
5 biotech career paths where demand is skyrocketing
Check out five important biotechnology careers that are currently in high demand, and likely still will be in the coming years.
News and Trends 7 Dec 2023
BIO-Europe 2023: top ten highlights
The biopharma community met at Munich in Germany for BIO-Europe 2023, where attendees from across the world took part in networking events to foster collaboration, last month. With a turnout of nearly 6000 participants and more than 150 exhibitors, the event hosted a number of panel discussions. In collaboration with our parent company, life science […]
Opinion 29 Nov 2023
Redefining drug development: the trailblazing evolution of the pharmaceutical industry
Drug discovery and development is a long, costly, and high-risk process that takes over 10 to 15 years with an average cost of over $1 to $2 billion for each new drug to be approved for clinical use. For any pharmaceutical company or academic institution, it is a big achievement to advance a drug candidate […]
Podcast 3 Nov 2023
Is quantum computing the future of drug discovery?
In this episode, we explore the synergy of quantum computing and drug discovery with the chief scientific officer and co-founder of Qubit Pharmaceuticals, Jean-Philip Piquemal. Qubit Pharmaceuticals was founded in 2020 with the vision of co-developing, with pharmaceutical and biotech companies, new, more effective, and safer drugs. The company uses its Atlas platform to discover […]
In Depth 31 Aug 2023
3D-printed tumors: startup hopes to drive cancer drug discovery
3D printing is capturing attention in the field of medicine of late. With the first 3D-printed drug being approved for the treatment of seizures, eight years ago, it was a consequential moment in healthcare, following which biotechs raced to step up personalized treatment. Now, with Chinese healthcare company Triastek turning heads after announcing promising clinical […]
In Depth 21 Jul 2023
How AI is shaping clinical research and trials
Artificial intelligence (AI) is everywhere at the minute, seemingly being used in some capacity in almost every professional industry, including clinical research and trials. In fact, it is fair to say that AI has taken the biotech industry by storm, and the hype surrounding it has led to numerous AI startup companies coming onto the […]
ADVERTISEMENT
